{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T18:29:38Z","timestamp":1778178578483,"version":"3.51.4"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T00:00:00Z","timestamp":1676332800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T00:00:00Z","timestamp":1676332800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Research fund of the state of Tyrol","award":["Project GZ 71934, J.LR."],"award-info":[{"award-number":["Project GZ 71934, J.LR."]}]},{"name":"Investigator-Initiated Study","award":["IIS 1199-0424, I.Ta"],"award-info":[{"award-number":["IIS 1199-0424, I.Ta"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The severity of coronavirus disease 2019 (COVID-19) is related to the presence of comorbidities including metabolic diseases. We herein present data from the longitudinal prospective CovILD trial, and investigate the recovery from COVID-19 in individuals with dysglycemia and dyslipidemia. A total of 145 COVID-19 patients were prospectively followed and a comprehensive clinical, laboratory and imaging assessment was performed at 60, 100, 180, and 360\u00a0days after the onset of COVID-19. The severity of acute COVID-19 and outcome at early post-acute follow-up were significantly related to the presence of dysglycemia and dyslipidemia. Still, at long-term follow-up, metabolic disorders were not associated with an adverse pulmonary outcome, as reflected by a good recovery of structural lung abnormalities in both, patients with and without metabolic diseases. To conclude, dyslipidemia and dysglycemia are associated with a more severe course of acute COVID-19 as well as delayed\u00a0early recovery but do not impair long-term pulmonary recovery.<\/jats:p>","DOI":"10.1038\/s41598-023-29654-1","type":"journal-article","created":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T11:07:56Z","timestamp":1676372876000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Pulmonary recovery from COVID-19 in patients with metabolic diseases: a longitudinal prospective cohort study"],"prefix":"10.1038","volume":"13","author":[{"given":"Thomas","family":"Sonnweber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Grubwieser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Pizzini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Boehm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabina","family":"Sahanic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Luger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Schwabl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerlig","family":"Widmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Egger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregor","family":"Hoermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewald","family":"W\u00f6ll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"Puchner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Kaser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor","family":"Theurl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manfred","family":"Nairz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Tymoszuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fcnter","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Joannidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"L\u00f6ffler-Ragg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Tancevski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,14]]},"reference":[{"key":"29654_CR1","doi-asserted-by":"publisher","first-page":"761887","DOI":"10.3389\/fmicb.2021.761887","volume":"12","author":"FR Burkert","year":"2021","unstructured":"Burkert, F. R., Lanser, L., Bellmann-Weiler, R. & Weiss, G. Coronavirus Disease 2019: Clinics, treatment, and prevention. Front. Microbiol. 12, 761887. https:\/\/doi.org\/10.3389\/fmicb.2021.761887 (2021).","journal-title":"Front. Microbiol."},{"key":"29654_CR2","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/S2213-8587(20)30238-2","volume":"8","author":"M Apicella","year":"2020","unstructured":"Apicella, M. et al. COVID-19 in people with diabetes: Understanding the reasons for worse outcomes. Lancet Diabetes Endocrinol. 8, 782\u2013792. https:\/\/doi.org\/10.1016\/S2213-8587(20)30238-2 (2020).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"29654_CR3","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1186\/s13098-020-00586-4","volume":"12","author":"B de Almeida-Pititto","year":"2020","unstructured":"de Almeida-Pititto, B. et al. Severity and mortality of COVID-19 in patients with diabetes, hypertension and cardiovascular disease: A meta-analysis. Diabetol. Metab Syndr. 12, 1758\u20135996. https:\/\/doi.org\/10.1186\/s13098-020-00586-4 (2020).","journal-title":"Diabetol. Metab Syndr."},{"key":"29654_CR4","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/j.dsx.2020.07.054","volume":"14","author":"TI Hariyanto","year":"2020","unstructured":"Hariyanto, T. I. & Kurniawan, A. Dyslipidemia is associated with severe coronavirus disease 2019 (COVID-19) infection. Diabetes Metab Syndr. 14, 1463\u20131465. https:\/\/doi.org\/10.1016\/j.dsx.2020.07.054 (2020).","journal-title":"Diabetes Metab Syndr."},{"key":"29654_CR5","doi-asserted-by":"publisher","first-page":"108374","DOI":"10.1016\/j.diabres.2020.108374","volume":"168","author":"GP Fadini","year":"2020","unstructured":"Fadini, G. P. et al. Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration. Diabetes Res. Clin. Pract. 168, 108374. https:\/\/doi.org\/10.1016\/j.diabres.2020.108374 (2020).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"29654_CR6","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1111\/dom.14099","volume":"22","author":"H Li","year":"2020","unstructured":"Li, H. et al. Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients with COVID-19. Diabetes Obes. Metab 22, 1897\u20131906. https:\/\/doi.org\/10.1111\/dom.14099 (2020).","journal-title":"Diabetes Obes. Metab"},{"key":"29654_CR7","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s40618-020-01236-2%M32222956","volume":"43","author":"GP Fadini","year":"2020","unstructured":"Fadini, G. P., Morieri, M. L., Longato, E. & Avogaro, A. Prevalence and impact of diabetes among people infected with SARS-CoV-2. J. Endocrinol. Invest. 43, 867\u2013869. https:\/\/doi.org\/10.1007\/s40618-020-01236-2%M32222956 (2020).","journal-title":"J. Endocrinol. Invest."},{"key":"29654_CR8","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00392-020-01626-9","volume":"109","author":"B Li","year":"2020","unstructured":"Li, B. et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin. Res. Cardiol 109, 531\u2013538. https:\/\/doi.org\/10.1007\/s00392-020-01626-9 (2020).","journal-title":"Clin. Res. Cardiol"},{"key":"29654_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41574-020-00435-4","volume":"17","author":"S Lim","year":"2021","unstructured":"Lim, S., Bae, J. H., Kwon, H. S. & Nauck, M. A. COVID-19 and diabetes mellitus: From pathophysiology to clinical management. Nat. Rev. Endocrinol. 17, 11\u201330. https:\/\/doi.org\/10.1038\/s41574-020-00435-4 (2021).","journal-title":"Nat. Rev. Endocrinol."},{"key":"29654_CR10","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3390\/v13122401","volume":"13","author":"F Aziz","year":"2021","unstructured":"Aziz, F. et al. COVID-19 in-hospital mortality in people with diabetes is driven by comorbidities and age-propensity score-matched analysis of Austrian National Public Health Institute Data. Viruses 13, 58. https:\/\/doi.org\/10.3390\/v13122401 (2021).","journal-title":"Viruses"},{"key":"29654_CR11","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1007\/s00508-021-01945-5","volume":"133","author":"T Mayerhofer","year":"2021","unstructured":"Mayerhofer, T. et al. Changes in characteristics and outcomes of critically ill COVID-19 patients in Tyrol (Austria) over 1 year. Wien. Klin. Wochenschr. 133, 1237\u20131247. https:\/\/doi.org\/10.1007\/s00508-021-01945-5 (2021).","journal-title":"Wien. Klin. Wochenschr."},{"key":"29654_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2021.01.007","author":"IS Atmosudigdo","year":"2021","unstructured":"Atmosudigdo, I. S. et al. Dyslipidemia increases the risk of severe COVID-19: A systematic review, meta-analysis, and meta-regression. J. Clin. Exp. Hepatol. https:\/\/doi.org\/10.1016\/j.jceh.2021.01.007 (2021).","journal-title":"J. Clin. Exp. Hepatol."},{"key":"29654_CR13","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jinf.2021.03.001","volume":"82","author":"H Yang","year":"2021","unstructured":"Yang, H., Hou, H., Liang, X., Xu, J. & Wang, Y. Lack of significant association between dyslipidemia and COVID-19 mortality. J. Infect. 82, 276\u2013316. https:\/\/doi.org\/10.1016\/j.jinf.2021.03.001 (2021).","journal-title":"J. Infect."},{"key":"29654_CR14","doi-asserted-by":"publisher","first-page":"435","DOI":"10.12997\/jla.2020.9.3.435","volume":"9","author":"GJ Choi","year":"2020","unstructured":"Choi, G. J., Kim, H. M. & Kang, H. The potential role of dyslipidemia in COVID-19 severity: An umbrella review of systematic reviews. J. Lipid Atheroscler 9, 435\u2013448. https:\/\/doi.org\/10.12997\/jla.2020.9.3.435 (2020).","journal-title":"J. Lipid Atheroscler"},{"key":"29654_CR15","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.cca.2021.02.011","volume":"517","author":"Y Li","year":"2021","unstructured":"Li, Y. et al. Lipid metabolism changes in patients with severe COVID-19. Clinica Chimica Acta 517, 66\u201373. https:\/\/doi.org\/10.1016\/j.cca.2021.02.011 (2021).","journal-title":"Clinica Chimica Acta"},{"key":"29654_CR16","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1007\/s10096-019-03543-w","volume":"38","author":"A Pizzini","year":"2019","unstructured":"Pizzini, A. et al. The impact of bacteremia on lipoprotein concentrations and patient\u2019s outcome: A retrospective analysis. Eur. J. Clin. Microbiol. Infect. Dis. 38, 1279\u20131286. https:\/\/doi.org\/10.1007\/s10096-019-03543-w (2019).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"29654_CR17","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nri3793","volume":"15","author":"AR Tall","year":"2015","unstructured":"Tall, A. R. & Yvan-Charvet, L. Cholesterol, inflammation and innate immunity. Nat. Rev. Immunol. 15, 104\u2013116. https:\/\/doi.org\/10.1038\/nri3793 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"29654_CR18","doi-asserted-by":"publisher","first-page":"862999","DOI":"10.3389\/fcvm.2022.862999","volume":"9","author":"V Chidambaram","year":"2022","unstructured":"Chidambaram, V. et al. Association of lipid levels with COVID-19 infection, disease severity and mortality: A systematic review and meta-analysis. Front. Cardiovasc. Med. 9, 862999. https:\/\/doi.org\/10.3389\/fcvm.2022.862999 (2022).","journal-title":"Front. Cardiovasc. Med."},{"key":"29654_CR19","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.140289","author":"JG Wilson","year":"2020","unstructured":"Wilson, J. G. et al. Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.140289 (2020).","journal-title":"JCI Insight"},{"key":"29654_CR20","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1172\/jci31539","volume":"118","author":"L Cai","year":"2008","unstructured":"Cai, L., Ji, A., de Beer, F. C., Tannock, L. R. & van der Westhuyzen, D. R. SR-BI protects against endotoxemia in mice through its roles in glucocorticoid production and hepatic clearance. J. Clin. Investig. 118, 364\u2013375. https:\/\/doi.org\/10.1172\/jci31539 (2008).","journal-title":"J. Clin. Investig."},{"key":"29654_CR21","doi-asserted-by":"publisher","first-page":"161","DOI":"10.23750\/abm.v91i1.9402","volume":"91","author":"M Baglivo","year":"2020","unstructured":"Baglivo, M. et al. Natural small molecules as inhibitors of coronavirus lipid-dependent attachment to host cells: A possible strategy for reducing SARS-COV-2 infectivity?. Acta Biomed. 91, 161\u2013164. https:\/\/doi.org\/10.23750\/abm.v91i1.9402 (2020).","journal-title":"Acta Biomed."},{"key":"29654_CR22","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1007\/s00705-018-3967-7","volume":"163","author":"JH Jeon","year":"2018","unstructured":"Jeon, J. H. & Lee, C. Cholesterol is important for the entry process of porcine deltacoronavirus. Adv. Virol. 163, 3119\u20133124. https:\/\/doi.org\/10.1007\/s00705-018-3967-7 (2018).","journal-title":"Adv. Virol."},{"key":"29654_CR23","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.micinf.2006.10.015","volume":"9","author":"GM Li","year":"2007","unstructured":"Li, G. M., Li, Y. G., Yamate, M., Li, S. M. & Ikuta, K. Lipid rafts play an important role in the early stage of severe acute respiratory syndrome-coronavirus life cycle. Microbes Infect. 9, 96\u2013102. https:\/\/doi.org\/10.1016\/j.micinf.2006.10.015 (2007).","journal-title":"Microbes Infect."},{"key":"29654_CR24","doi-asserted-by":"publisher","DOI":"10.1101\/2020.05.09.086249","author":"H Wang","year":"2021","unstructured":"Wang, H. et al. The role of high cholesterol in age-related COVID19 lethality. bioRxiv https:\/\/doi.org\/10.1101\/2020.05.09.086249 (2021).","journal-title":"bioRxiv"},{"key":"29654_CR25","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1164\/rccm.202105-1197TR","volume":"205","author":"DA Hofmaenner","year":"2022","unstructured":"Hofmaenner, D. A., Kleyman, A., Press, A., Bauer, M. & Singer, M. The many roles of cholesterol in sepsis: A review. Am. J. Respir. Crit. Care Med. 205, 388\u2013396. https:\/\/doi.org\/10.1164\/rccm.202105-1197TR (2022).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"29654_CR26","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.jacl.2021.08.002","volume":"15","author":"W Dai","year":"2021","unstructured":"Dai, W. et al. Hypertriglyceridemia during hospitalization independently associates with mortality in patients with COVID-19. J. Clin. Lipidol. 15, 724\u2013731. https:\/\/doi.org\/10.1016\/j.jacl.2021.08.002 (2021).","journal-title":"J. Clin. Lipidol."},{"key":"29654_CR27","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1161\/01.ATV.0000259361.91267.8c","volume":"27","author":"A Wehinger","year":"2007","unstructured":"Wehinger, A. et al. Phospholipid transfer protein augments apoptosis in THP-1-derived macrophages induced by lipolyzed hypertriglyceridemic plasma. Arterioscler. Thromb. Vasc. Biol. 27, 908\u2013915. https:\/\/doi.org\/10.1161\/01.ATV.0000259361.91267.8c (2007).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"29654_CR28","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nature21363","volume":"542","author":"GS Hotamisligil","year":"2017","unstructured":"Hotamisligil, G. S. Inflammation, metaflammation and immunometabolic disorders. Nature 542, 177\u2013185. https:\/\/doi.org\/10.1038\/nature21363 (2017).","journal-title":"Nature"},{"key":"29654_CR29","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1172\/JCI57132","volume":"121","author":"CN Lumeng","year":"2011","unstructured":"Lumeng, C. N. & Saltiel, A. R. Inflammatory links between obesity and metabolic disease. J. Clin. Investig. 121, 2111\u20132117. https:\/\/doi.org\/10.1172\/JCI57132 (2011).","journal-title":"J. Clin. Investig."},{"key":"29654_CR30","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/27376","volume":"395","author":"JM Friedman","year":"1998","unstructured":"Friedman, J. M. & Halaas, J. L. Leptin and the regulation of body weight in mammals. Nature 395, 763\u2013770. https:\/\/doi.org\/10.1038\/27376 (1998).","journal-title":"Nature"},{"key":"29654_CR31","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/j.1467-789X.2009.00571.x","volume":"10","author":"C Antoniades","year":"2009","unstructured":"Antoniades, C., Antonopoulos, A. S., Tousoulis, D. & Stefanadis, C. Adiponectin: From obesity to cardiovascular disease. Obes Rev 10, 269\u2013279. https:\/\/doi.org\/10.1111\/j.1467-789X.2009.00571.x (2009).","journal-title":"Obes Rev"},{"key":"29654_CR32","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cca.2007.01.026","volume":"380","author":"N Ouchi","year":"2007","unstructured":"Ouchi, N. & Walsh, K. Adiponectin as an anti-inflammatory factor. Clinica Chimica Acta 380, 24\u201330. https:\/\/doi.org\/10.1016\/j.cca.2007.01.026 (2007).","journal-title":"Clinica Chimica Acta"},{"key":"29654_CR33","doi-asserted-by":"publisher","first-page":"101268","DOI":"10.1016\/j.diabet.2021.101268","volume":"47","author":"L Di Filippo","year":"2021","unstructured":"Di Filippo, L. et al. Adiponectin to leptin ratio reflects inflammatory burden and survival in COVID-19. Diabetes Metab 47, 101268. https:\/\/doi.org\/10.1016\/j.diabet.2021.101268 (2021).","journal-title":"Diabetes Metab"},{"key":"29654_CR34","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1016\/j.cmet.2021.09.009","volume":"33","author":"M Reiterer","year":"2021","unstructured":"Reiterer, M. et al. Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2. Cell Metabol. 33, 2174-2188 e2175. https:\/\/doi.org\/10.1016\/j.cmet.2021.09.009 (2021).","journal-title":"Cell Metabol."},{"key":"29654_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cmet.2021.12.002","volume":"34","author":"M Zickler","year":"2022","unstructured":"Zickler, M. et al. Replication of SARS-CoV-2 in adipose tissue determines organ and systemic lipid metabolism in hamsters and humans. Cell Metab. 34, 1\u20132. https:\/\/doi.org\/10.1016\/j.cmet.2021.12.002 (2022).","journal-title":"Cell Metab."},{"key":"29654_CR36","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.03481-2020","author":"T Sonnweber","year":"2020","unstructured":"Sonnweber, T. et al. Cardiopulmonary recovery after COVID-19-an observational prospective multi-center trial. Eur. Respir. J. https:\/\/doi.org\/10.1183\/13993003.03481-2020 (2020).","journal-title":"Eur. Respir. J."},{"key":"29654_CR37","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.72500","author":"T Sonnweber","year":"2022","unstructured":"Sonnweber, T. et al. Investigating phenotypes of pulmonary COVID-19 recovery-a longitudinal observational prospective multicenter trial. Elife https:\/\/doi.org\/10.7554\/eLife.72500 (2022).","journal-title":"Elife"},{"key":"29654_CR38","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s12931-020-01546-2","volume":"21","author":"T Sonnweber","year":"2020","unstructured":"Sonnweber, T. et al. Persisting alterations of iron homeostasis in COVID-19 are associated with non-resolving lung pathologies and poor patients\u2019 performance: A prospective observational cohort study. Respir. Res. 21, 276. https:\/\/doi.org\/10.1186\/s12931-020-01546-2 (2020).","journal-title":"Respir. Res."},{"key":"29654_CR39","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1515\/cclm-2021-0214","volume":"59","author":"C Irsara","year":"2021","unstructured":"Irsara, C. et al. Clinical validation of the Siemens quantitative SARS-CoV-2 spike IgG assay (sCOVG) reveals improved sensitivity and a good correlation with virus neutralization titers. Clin. Chem. Lab. Med. 59, 1453\u20131462. https:\/\/doi.org\/10.1515\/cclm-2021-0214 (2021).","journal-title":"Clin. Chem. Lab. Med."},{"key":"29654_CR40","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.dsx.2018.10.006","volume":"13","author":"B Pantoja-Torres","year":"2019","unstructured":"Pantoja-Torres, B. et al. High triglycerides to HDL-cholesterol ratio is associated with insulin resistance in normal-weight healthy adults. Diabetes Metab Syndr 13, 382\u2013388. https:\/\/doi.org\/10.1016\/j.dsx.2018.10.006 (2019).","journal-title":"Diabetes Metab Syndr"},{"key":"29654_CR41","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou, F. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet 395, 1054\u20131062. https:\/\/doi.org\/10.1016\/S0140-6736(20)30566-3 (2020).","journal-title":"Lancet"},{"key":"29654_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30116-8","author":"L Fang","year":"2020","unstructured":"Fang, L., Karakiulakis, G. & Roth, M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?. The Lancet. https:\/\/doi.org\/10.1016\/S2213-2600(20)30116-8 (2020).","journal-title":"The Lancet."},{"key":"29654_CR43","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1016\/S0140-6736(20)31189-2","volume":"395","author":"MJ Cummings","year":"2020","unstructured":"Cummings, M. J. et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: A prospective cohort study. Lancet 395, 1763\u20131770. https:\/\/doi.org\/10.1016\/S0140-6736(20)31189-2 (2020).","journal-title":"Lancet"},{"key":"29654_CR44","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.dsx.2020.04.018","volume":"14","author":"I Huang","year":"2020","unstructured":"Huang, I., Lim, M. A. & Pranata, R. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia-A systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr 14, 395\u2013403. https:\/\/doi.org\/10.1016\/j.dsx.2020.04.018 (2020).","journal-title":"Diabetes Metab Syndr"},{"key":"29654_CR45","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S2213-8587(20)30272-2","volume":"8","author":"E Barron","year":"2020","unstructured":"Barron, E. et al. Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: A whole-population study. Lancet Diabetes Endocrinol 8, 813\u2013822. https:\/\/doi.org\/10.1016\/S2213-8587(20)30272-2 (2020).","journal-title":"Lancet Diabetes Endocrinol"},{"key":"29654_CR46","doi-asserted-by":"publisher","first-page":"102307","DOI":"10.1016\/j.dsx.2021.102307","volume":"15","author":"M Heidarpour","year":"2021","unstructured":"Heidarpour, M., Abhari, A. P., Sadeghpour, N., Shafie, D. & Sarokhani, D. Prediabetes and COVID-19 severity, an underestimated risk factor: A systematic review and meta-analysis. Diabetes Metab Syndr 15, 102307. https:\/\/doi.org\/10.1016\/j.dsx.2021.102307 (2021).","journal-title":"Diabetes Metab Syndr"},{"key":"29654_CR47","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/s13054-021-03730-2","volume":"25","author":"SJ Klein","year":"2021","unstructured":"Klein, S. J. et al. Elevated HbA1c remains a predominant finding in severe COVID-19 and may be associated with increased mortality in patients requiring mechanical ventilation. Crit. Care 25, 300. https:\/\/doi.org\/10.1186\/s13054-021-03730-2 (2021).","journal-title":"Crit. Care"},{"key":"29654_CR48","doi-asserted-by":"publisher","first-page":"578","DOI":"10.2337\/dc20-1857","volume":"44","author":"DC Klonoff","year":"2021","unstructured":"Klonoff, D. C. et al. Association between achieving inpatient glycemic control and clinical outcomes in hospitalized patients with COVID-19: A multicentre, retrospective hospital-based analysis. Diabetes Care 44, 578\u2013585. https:\/\/doi.org\/10.2337\/dc20-1857 (2021).","journal-title":"Diabetes Care"},{"key":"29654_CR49","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.amjms.2015.11.011","volume":"351","author":"N Jafar","year":"2016","unstructured":"Jafar, N., Edriss, H. & Nugent, K. The effect of short-term hyperglycemia on the innate immune system. Am. J. Med. Sci. 351, 201\u2013211. https:\/\/doi.org\/10.1016\/j.amjms.2015.11.011 (2016).","journal-title":"Am. J. Med. Sci."},{"key":"29654_CR50","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","volume":"395","author":"Z Varga","year":"2020","unstructured":"Varga, Z. et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet 395, 1417\u20131418. https:\/\/doi.org\/10.1016\/S0140-6736(20)30937-5 (2020).","journal-title":"Lancet"},{"key":"29654_CR51","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.2337\/dc20-0723","volume":"43","author":"C Sardu","year":"2020","unstructured":"Sardu, C. et al. Outcomes in patients with hyperglycemia affected by COVID-19: can we do more on glycemic control?. Diabetes Care 43, 1408\u20131415. https:\/\/doi.org\/10.2337\/dc20-0723 (2020).","journal-title":"Diabetes Care"},{"key":"29654_CR52","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-042220-011857","author":"AK Singh","year":"2021","unstructured":"Singh, A. K. & Khunti, K. COVID-19 and diabetes. Annu. Rev. Med. https:\/\/doi.org\/10.1146\/annurev-med-042220-011857 (2021).","journal-title":"Annu. Rev. Med."},{"key":"29654_CR53","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1186\/s13054-020-03139-3","volume":"24","author":"SJ Klein","year":"2020","unstructured":"Klein, S. J. et al. Unrecognized diabetes in critically ill COVID-19 patients. Crit Care 24, 406. https:\/\/doi.org\/10.1186\/s13054-020-03139-3 (2020).","journal-title":"Crit Care"},{"key":"29654_CR54","doi-asserted-by":"publisher","first-page":"154216","DOI":"10.1016\/j.metabol.2020.154216","volume":"107","author":"J Zhou","year":"2020","unstructured":"Zhou, J. & Tan, J. Diabetes patients with COVID-19 need better blood glucose management in Wuhan, China. Metabolism 107, 154216. https:\/\/doi.org\/10.1016\/j.metabol.2020.154216 (2020).","journal-title":"Metabolism"},{"key":"29654_CR55","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s12020-022-03096-7","volume":"77","author":"L di Filippo","year":"2022","unstructured":"di Filippo, L. et al. Vertebral fractures at hospitalization predict impaired respiratory function during follow-up of COVID-19 survivors. Endocrine 77, 392\u2013400. https:\/\/doi.org\/10.1007\/s12020-022-03096-7 (2022).","journal-title":"Endocrine"},{"key":"29654_CR56","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/cc10021","volume":"15","author":"K Robinson","year":"2011","unstructured":"Robinson, K., Prins, J. & Venkatesh, B. Clinical review: Adiponectin biology and its role in inflammation and critical illness. Crit. Care 15, 221. https:\/\/doi.org\/10.1186\/cc10021 (2011).","journal-title":"Crit. Care"},{"key":"29654_CR57","doi-asserted-by":"publisher","first-page":"e14843","DOI":"10.14814\/phy2.14843","volume":"9","author":"SM Kearns","year":"2021","unstructured":"Kearns, S. M. et al. Reduced adiponectin levels in patients with COVID-19 acute respiratory failure: A case-control study. Physiol. Rep. 9, e14843. https:\/\/doi.org\/10.14814\/phy2.14843 (2021).","journal-title":"Physiol. Rep."},{"key":"29654_CR58","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.2337\/dc21-1318","volume":"44","author":"K Khunti","year":"2021","unstructured":"Khunti, K. et al. COVID-19, hyperglycemia, and new-onset diabetes. Diabetes Care 44, 2645\u20132655. https:\/\/doi.org\/10.2337\/dc21-1318 (2021).","journal-title":"Diabetes Care"},{"key":"29654_CR59","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.mayocp.2016.12.020","volume":"92","author":"CJ Jivanji","year":"2017","unstructured":"Jivanji, C. J., Asrani, V. M., Windsor, J. A. & Petrov, M. S. New-onset diabetes after acute and critical Illness: A systematic review. Mayo Clin. Proc. 92, 762\u2013773. https:\/\/doi.org\/10.1016\/j.mayocp.2016.12.020 (2017).","journal-title":"Mayo Clin. Proc."},{"key":"29654_CR60","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1177\/1932296820924469","volume":"14","author":"B Bode","year":"2020","unstructured":"Bode, B. et al. Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the United States. J Diabetes Sci Technol 14, 813\u2013821. https:\/\/doi.org\/10.1177\/1932296820924469 (2020).","journal-title":"J Diabetes Sci Technol"},{"key":"29654_CR61","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1111\/dom.14269","volume":"23","author":"T Sathish","year":"2021","unstructured":"Sathish, T., Kapoor, N., Cao, Y., Tapp, R. J. & Zimmet, P. Proportion of newly diagnosed diabetes in COVID-19 patients: A systematic review and meta-analysis. Diabetes Obes. Metab 23, 870\u2013874. https:\/\/doi.org\/10.1111\/dom.14269 (2021).","journal-title":"Diabetes Obes. Metab"},{"key":"29654_CR62","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.2337\/dc20-1088","volume":"43","author":"OA Ebekozien","year":"2020","unstructured":"Ebekozien, O. A., Noor, N., Gallagher, M. P. & Alonso, G. T. Type 1 diabetes and COVID-19: Preliminary findings from a multicenter surveillance study in the U.S. Diabetes care 43, e83\u2013e85. https:\/\/doi.org\/10.2337\/dc20-1088 (2020).","journal-title":"Diabetes care"},{"key":"29654_CR63","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.2337\/dc20-1380","volume":"43","author":"A Coppelli","year":"2020","unstructured":"Coppelli, A. et al. Hyperglycemia at hospital admission is associated with severity of the prognosis in patients hospitalized for COVID-19: The Pisa COVID-19 study. Diabetes Care 43, 2345\u20132348. https:\/\/doi.org\/10.2337\/dc20-1380 (2020).","journal-title":"Diabetes Care"},{"key":"29654_CR64","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s13054-016-1471-6","volume":"20","author":"Y Ali Abdelhamid","year":"2016","unstructured":"Ali Abdelhamid, Y. et al. Stress hyperglycaemia in critically ill patients and the subsequent risk of diabetes: A systematic review and meta-analysis. Crit Care 20, 301. https:\/\/doi.org\/10.1186\/s13054-016-1471-6 (2016).","journal-title":"Crit Care"},{"key":"29654_CR65","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/j.cgh.2020.04.040","volume":"18","author":"F Liu","year":"2020","unstructured":"Liu, F. et al. ACE2 expression in pancreas may cause pancreatic damage after SARS-CoV-2 infection. Clin. Gastroenterol. Hepatol. 18, 2128-2130.e2122. https:\/\/doi.org\/10.1016\/j.cgh.2020.04.040 (2020).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"29654_CR66","doi-asserted-by":"publisher","first-page":"596898","DOI":"10.3389\/fendo.2020.596898","volume":"11","author":"D Fignani","year":"2020","unstructured":"Fignani, D. et al. SARS-CoV-2 receptor angiotensin I-converting enzyme type 2 (ACE2) is expressed in human pancreatic \u03b2-cells and in the human pancreas microvasculature. Front. Endocrinol. (Lausanne) 11, 596898. https:\/\/doi.org\/10.3389\/fendo.2020.596898 (2020).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"29654_CR67","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/s2213-8587(21)00087-5","volume":"9","author":"MA Atkinson","year":"2021","unstructured":"Atkinson, M. A. & Powers, A. C. Distinguishing the real from the hyperglycaemia: Does COVID-19 induce diabetes?. Lancet Diabetes Endocrinol 9, 328\u2013329. https:\/\/doi.org\/10.1016\/s2213-8587(21)00087-5 (2021).","journal-title":"Lancet Diabetes Endocrinol"},{"key":"29654_CR68","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.cmet.2020.11.005","volume":"32","author":"I Kusmartseva","year":"2020","unstructured":"Kusmartseva, I. et al. Expression of SARS-CoV-2 entry factors in the pancreas of normal organ donors and individuals with COVID-19. Cell Metab. 32, 1041-1051.e1046. https:\/\/doi.org\/10.1016\/j.cmet.2020.11.005 (2020).","journal-title":"Cell Metab."},{"key":"29654_CR69","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/s2213-8587(18)30051-2","volume":"6","author":"E Ahlqvist","year":"2018","unstructured":"Ahlqvist, E. et al. Novel subgroups of adult-onset diabetes and their association with outcomes: A data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol. 6, 361\u2013369. https:\/\/doi.org\/10.1016\/s2213-8587(18)30051-2 (2018).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"29654_CR70","doi-asserted-by":"publisher","first-page":"678482","DOI":"10.3389\/fcimb.2021.678482","volume":"11","author":"SH Shaharuddin","year":"2021","unstructured":"Shaharuddin, S. H. et al. Deleterious effects of SARS-CoV-2 infection on human pancreatic cells. Front. Cell. Infect. Microbiol. 11, 678482. https:\/\/doi.org\/10.3389\/fcimb.2021.678482 (2021).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"29654_CR71","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/j.cmet.2021.05.013","volume":"33","author":"CT Wu","year":"2021","unstructured":"Wu, C. T. et al. SARS-CoV-2 infects human pancreatic \u03b2 cells and elicits \u03b2 cell impairment. Cell Metab. 33, 1565-1576.e1565. https:\/\/doi.org\/10.1016\/j.cmet.2021.05.013 (2021).","journal-title":"Cell Metab."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-29654-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-29654-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-29654-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T11:20:54Z","timestamp":1676373654000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-29654-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,14]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["29654"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-29654-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,14]]},"assertion":[{"value":"28 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2599"}}